Johnson & Johnson reports $2.90 EPS and $25.31B revenue, exceeding expectations and raising its FY26 outlook.
Johnson & Johnson posted Q2 non-GAAP earnings of $2.90 per share, beating estimates by $0.05, on revenue of $25.31 billion, up 6.8% year-over-year and $250 million above forecasts. Operational growth reached 5.6%, with adjusted operational growth at 5.7%.
The results surpass prior expectations, reflecting stronger-than-anticipated performance across key segments. The company’s previous quarter had set a lower benchmark, with revenue growth of 4.3% and EPS of $2.71.
Following the release, Johnson & Johnson raised its full-year 2026 outlook, citing robust operational execution and market demand.